Eurazeo SE (EUZOF) Q4 2025 Earnings Call Transcript

Fundraising hit EUR 5.5bn in 2025, up 28% YoY, while third‑party AUM rose 15% and wealth AUM increased 16%. Third‑party management fees in Private Markets grew 10%, FRE margin improved to 36% (+40bps YoY) and PREs from third parties tripled to EUR 11m. Balance sheet realizations increased 44% to EUR 1.5bn, indicating stronger rotation and improved profitability.

Analysis

Eurazeo sits at an inflection where recurring fee economics are starting to dominate earnings cadence, which reduces earnings beta to deal timing and shifts value capture toward distribution and productization. That makes the stock more sensitive to multiple expansion tied to sustainable fee growth rather than one-off exit gains, so the immediate re-rate vector is clarity on forward fee visibility and renewal success over the next 6–12 months.

Second-order winners include European wealth platforms, placement agents and listed managers that can OEM distribution into the same institutional channels — they will see easier AUM arbitrage as block capital reflows from realizations are recycled into fee-bearing products. Conversely, GPs still heavily dependent on NAV-based performance fees or older vintages with concentrated exposure are at risk of relative underperformance as limited partners rotate to managers showing repeatable third-party flows.

Primary tail risks are a liquidity or fundraising shock that re-prices the private markets entry/exit multiple and a slowdown in exit markets that shifts realizations back onto the balance sheet; both could compress near-term EPS and suspend multiple expansion. Key catalysts to watch over the next 3–12 months are fundraising closes for new third-party vehicles, the cadence of announced portfolio exits and any sharp change in the European institutional buying cycle (pension/insurer allocations).

Key Decisions for Investors

• Long EUZOF (Eurazeo SE) — buy at market, 6–12 month horizon. Target asymmetric upside of ~+35–50% on continued fee growth and multiple re-rating; set tactical stop-loss at -20% to protect against a fundraising shock.
• Relative pair: Long EUZOF / Short EQT.ST (EQT) — equal notional, 6–12 month horizon. Expresses manager-specific execution and distribution premium while hedging macro private-market valuation moves; target 200–400bps annualized relative outperformance, stop if spread moves against position by >30%.
• Buy downside protection on EUZOF — purchase 6–12 month put options sized to ~25–30% notional. Cost is insurance against a fast reversal in fundraising/exit environment; preserves upside from long exposure while limiting tail loss to pre-defined premium (budget ~2–4% of position value).